Utility of LRF/pokemon and NOTCH1 protein expression in the distinction between nodular lymphocyte-predominant hodgkin lymphoma and classical hodgkin lymphoma

Olga Bohn, Takahiro Maeda, Alexander Filatov, Andrea Lunardi, Pier Paolo Pandolfi, Julie Teruya-Feldstein

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Classical Hodgkin lymphoma (CHL) and nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) are considered separate entities with different prognosis and treatment. However, morphologic features can be similar and immunohistochemical studies are essential in the distinction; thus, determination of additional biomarkers is of utmost importance. LRF/Pokemon is a proto-oncogene, an interacting partner co-expressed with BCL6 in germinal centers and highly expressed in diffuse large B-cell lymphoma and follicular lymphoma. Conversely, loss of the LRF gene in mouse hematopoietic stem cells results in complete block of early B cell development with concomitant Notch de-repression, indicating its critical role in B versus T cell fate decision at the hematopoietic stem cell stage. For the first time, we show that LRF/Pokemon is predominantly expressed in NLPHL cases as is BCL6 with low to absent NOTCH1 protein expression; while Hodgkin Reed-Sternberg (HRS) cells in CHL show low to absent BCL6 and LRF/Pokemon expression with higher NOTCH1 expression. We illustrate a potential functional interaction between LRF and BCL6 in NLPHL pathogenesis, and differential expression of LRF/Pokemon and NOTCH1 proteins in CHL thus showing differential expression, making for an additional diagnostic marker and therapeutic target.

Original languageEnglish
Pages (from-to)6-11
Number of pages6
JournalInternational Journal of Surgical Pathology
Volume22
Issue number1
DOIs
Publication statusPublished - Feb 1 2014
Externally publishedYes

Fingerprint

Hodgkin Disease
Proteins
Hematopoietic Stem Cells
Reed-Sternberg Cells
Follicular Lymphoma
Germinal Center
Proto-Oncogenes
Lymphoma, Large B-Cell, Diffuse
B-Lymphocytes
Biomarkers
T-Lymphocytes
Genes

All Science Journal Classification (ASJC) codes

  • Anatomy
  • Surgery
  • Pathology and Forensic Medicine

Cite this

Utility of LRF/pokemon and NOTCH1 protein expression in the distinction between nodular lymphocyte-predominant hodgkin lymphoma and classical hodgkin lymphoma. / Bohn, Olga; Maeda, Takahiro; Filatov, Alexander; Lunardi, Andrea; Pandolfi, Pier Paolo; Teruya-Feldstein, Julie.

In: International Journal of Surgical Pathology, Vol. 22, No. 1, 01.02.2014, p. 6-11.

Research output: Contribution to journalArticle

@article{e7dda92e5fae46a7ad133bbd1ed3cb20,
title = "Utility of LRF/pokemon and NOTCH1 protein expression in the distinction between nodular lymphocyte-predominant hodgkin lymphoma and classical hodgkin lymphoma",
abstract = "Classical Hodgkin lymphoma (CHL) and nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) are considered separate entities with different prognosis and treatment. However, morphologic features can be similar and immunohistochemical studies are essential in the distinction; thus, determination of additional biomarkers is of utmost importance. LRF/Pokemon is a proto-oncogene, an interacting partner co-expressed with BCL6 in germinal centers and highly expressed in diffuse large B-cell lymphoma and follicular lymphoma. Conversely, loss of the LRF gene in mouse hematopoietic stem cells results in complete block of early B cell development with concomitant Notch de-repression, indicating its critical role in B versus T cell fate decision at the hematopoietic stem cell stage. For the first time, we show that LRF/Pokemon is predominantly expressed in NLPHL cases as is BCL6 with low to absent NOTCH1 protein expression; while Hodgkin Reed-Sternberg (HRS) cells in CHL show low to absent BCL6 and LRF/Pokemon expression with higher NOTCH1 expression. We illustrate a potential functional interaction between LRF and BCL6 in NLPHL pathogenesis, and differential expression of LRF/Pokemon and NOTCH1 proteins in CHL thus showing differential expression, making for an additional diagnostic marker and therapeutic target.",
author = "Olga Bohn and Takahiro Maeda and Alexander Filatov and Andrea Lunardi and Pandolfi, {Pier Paolo} and Julie Teruya-Feldstein",
year = "2014",
month = "2",
day = "1",
doi = "10.1177/1066896913513833",
language = "English",
volume = "22",
pages = "6--11",
journal = "International Journal of Surgical Pathology",
issn = "1066-8969",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Utility of LRF/pokemon and NOTCH1 protein expression in the distinction between nodular lymphocyte-predominant hodgkin lymphoma and classical hodgkin lymphoma

AU - Bohn, Olga

AU - Maeda, Takahiro

AU - Filatov, Alexander

AU - Lunardi, Andrea

AU - Pandolfi, Pier Paolo

AU - Teruya-Feldstein, Julie

PY - 2014/2/1

Y1 - 2014/2/1

N2 - Classical Hodgkin lymphoma (CHL) and nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) are considered separate entities with different prognosis and treatment. However, morphologic features can be similar and immunohistochemical studies are essential in the distinction; thus, determination of additional biomarkers is of utmost importance. LRF/Pokemon is a proto-oncogene, an interacting partner co-expressed with BCL6 in germinal centers and highly expressed in diffuse large B-cell lymphoma and follicular lymphoma. Conversely, loss of the LRF gene in mouse hematopoietic stem cells results in complete block of early B cell development with concomitant Notch de-repression, indicating its critical role in B versus T cell fate decision at the hematopoietic stem cell stage. For the first time, we show that LRF/Pokemon is predominantly expressed in NLPHL cases as is BCL6 with low to absent NOTCH1 protein expression; while Hodgkin Reed-Sternberg (HRS) cells in CHL show low to absent BCL6 and LRF/Pokemon expression with higher NOTCH1 expression. We illustrate a potential functional interaction between LRF and BCL6 in NLPHL pathogenesis, and differential expression of LRF/Pokemon and NOTCH1 proteins in CHL thus showing differential expression, making for an additional diagnostic marker and therapeutic target.

AB - Classical Hodgkin lymphoma (CHL) and nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) are considered separate entities with different prognosis and treatment. However, morphologic features can be similar and immunohistochemical studies are essential in the distinction; thus, determination of additional biomarkers is of utmost importance. LRF/Pokemon is a proto-oncogene, an interacting partner co-expressed with BCL6 in germinal centers and highly expressed in diffuse large B-cell lymphoma and follicular lymphoma. Conversely, loss of the LRF gene in mouse hematopoietic stem cells results in complete block of early B cell development with concomitant Notch de-repression, indicating its critical role in B versus T cell fate decision at the hematopoietic stem cell stage. For the first time, we show that LRF/Pokemon is predominantly expressed in NLPHL cases as is BCL6 with low to absent NOTCH1 protein expression; while Hodgkin Reed-Sternberg (HRS) cells in CHL show low to absent BCL6 and LRF/Pokemon expression with higher NOTCH1 expression. We illustrate a potential functional interaction between LRF and BCL6 in NLPHL pathogenesis, and differential expression of LRF/Pokemon and NOTCH1 proteins in CHL thus showing differential expression, making for an additional diagnostic marker and therapeutic target.

UR - http://www.scopus.com/inward/record.url?scp=84893616003&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893616003&partnerID=8YFLogxK

U2 - 10.1177/1066896913513833

DO - 10.1177/1066896913513833

M3 - Article

VL - 22

SP - 6

EP - 11

JO - International Journal of Surgical Pathology

JF - International Journal of Surgical Pathology

SN - 1066-8969

IS - 1

ER -